|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Monoclonal-antibody-based therapeutic and preventative products. |
|
| Management |
| Elliott Fineman, President and CEO; James W. Larrick, Vice President and Chief Technical Officer; Jeffrey S. Price, Chairman |
| |
|
|
| |
|
| Keywords |
| cancer, cardiovascular disease, rheumatoid arthritis, monoclonal antibody, therapeutic |
|
|
|
| Description |
|
Planet Biotechnology develops monoclonal-antibody-based therapeutic and preventative products for the treatment of cancer, cardiovascular disease and rheumatoid arthritis. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members